Christopher Male

Pangea Ventures is a venture capital firm that focuses on investing in "hard tech" companies that leverage advanced materials science to solve fundamental problems in health and sustainability. While not a biotechnology company itself, the firm is a significant investor in the life sciences sector, backing startups involved in medical devices, diagnostics, and breakthrough healthcare technologies. The firm typically invests at the Seed and Series A stages, providing both capital and strategic guidance to help technical founders scale their innovations. Christopher Male is a co-founder and Managing Partner of the firm, playing a central role in its investment strategy and portfolio management.